Jonathan Jay Mazelsky, President & CEO at IDEXX LABORATORIES INC /DE (IDXX), sold 20,400 shares at $435.07 ($8.9M) on 2022-11-14, disclosed to the SEC on 2022-11-16.
Open-market sale of $8.9M IDXX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $433.37 | 972 | $421K | 4.8% |
| 2 | $433.37 | 972 | $421K | 4.8% |
| 3 | $434.26 | 6,385 | $2.8M | 31.3% |
| 4 | $434.26 | 6,385 | $2.8M | 31.3% |
| 5 | $435.07 | 2,543 | $1.1M | 12.5% |
| 6 | $435.07 | 2,543 |
| $1.1M |
| 12.5% |
| 7 | $435.88 | 600 | $262K | 3.0% |
| Total | $434.42 avg | 20,400 | $8.9M | 100% |
| Filing → |
| IDXX | SELL | 2024-02-09 | $13.7M | — | Filing → |
| IDXX | SELL | 2023-12-06 | $7.3M | — | Filing → |
| IDXX | SELL | 2023-09-05 | $13.7M | — | Filing → |